[Gyrase inhibitors. Central nervous side effects and inhibition of methylxanthine elimination].
Harder
S
S
Abteilung Klinische Pharmakologie, Universität Frankfurt/Main.
Shah
P M
PM
Staib
A H
AH
D042462:4-Quinolones; D000890:Anti-Infective Agents / Q000009:adverse effects* / Q000494:pharmacology; D002110:Caffeine / Q000493:pharmacokinetics / Q000494:pharmacology; D002490:Central Nervous System / Q000187:drug effects*; D004347:Drug Interactions; D004357:Drug Synergism; D006801:Humans; D013806:Theophylline / Q000493:pharmacokinetics / Q000494:pharmacology; D014970:Xanthines / Q000493:pharmacokinetics* / Q000494:pharmacology
D042462:4-Quinolones; D000890:Anti-Infective Agents; D014970:Xanthines; D002110:Caffeine; D013806:Theophylline
Gyrasehemmstoffe. Zentralnervöse Nebenwirkungen und Hemmung der Methylxanthinelimination.